CSI Market
Sign In | Register

Enzymotec Ltd. (ENZY) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ENZY Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Enzymotec Ltd. manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2016)
12 Months 		0 0 0 0
Operating Activities
Income-2.92
Depreciation & amortization2,577.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.54
Provision For Loan Losses Expensed0.94
Increase (Decrease) in Inventories4.52
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation2.58
Income (Loss) from Equity Method Investments0.39
Financial Instruments and Foreign Currency Transaction-0.31
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-5.60
Increase (Decrease) in Accounts Payable-1.89
Increase (Decrease) in Pension and Postretirement Obligations0.14
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-0.07
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities1.39
Investing Activities
Capital Expenditures2.11
Sale of Capital Items0.00
Short-term Investments Proceeds-1.86
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments For Proceeds From Marketable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Sale of Equity Method Investments0.06
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.03
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-15.98
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.19
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.19
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow3.50
Total Cash Flow-14.41
4 historic quarters locked

Sign in to unlock the full Enzymotec Ltd. cash flow history.

Sign In Create Free Account

About ENZY Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.